Literature DB >> 26435655

Ewing's sarcoma of the proximal phalanx of the foot: A rare case report.

G Togral1, M Arıkan1, E Benzer2, S Gungor1.   

Abstract

BACKGROUND: Ewing's sarcoma localized to foot is extremely rare. Local control is mandatory because of the aggressive nature of the tumor. Therapeutic options for these local tumors include neoadjuvant chemotherapy followed by surgery. DESCRIPTION OF THE CASE: A 17-year-old female patient presented with a 6-month history of progressive swelling and intermittent pain of the left great toe. Plain radiography and magnetic resonance imaging revealed an expansile mass that had originated from the proximal phalanx of the great toe and was destructing and surrounding the distal phalanx. Her erythrocyte sedimentation rate and serum lactate dehydrogenase levels were slightly elevated. Distant metastasis was not detected. The patient underwent an open biopsy, which confirmed the diagnosis of Ewing's sarcoma. She was treated with neoadjuvant chemotherapy and disarticulation above the metatarsophalangeal joint. She received adjuvant chemotherapy following the operation. The patient died 50 months after the operation as a result of disseminated disease.
CONCLUSION: The distal phalanx of the foot is an extremely rare site for the development of Ewing's sarcoma. As local control is important to avoid dissemination of the disease, neoadjuvant chemotherapy followed by amputation or disarticulation of the affected digit and subsequently adjuvant chemotherapy may be favorable modality for increasing the patient's duration of survival. Hippokratia 2015, 19 (1): 82-84.

Entities:  

Keywords:  Ewing’s sarcoma; disarticulation; foot; proximal phalanx

Year:  2015        PMID: 26435655      PMCID: PMC4574595     

Source DB:  PubMed          Journal:  Hippokratia        ISSN: 1108-4189            Impact factor:   0.471


  9 in total

1.  Ewing's sarcoma of the foot.

Authors:  C D Adkins; H B Kitaoka; R K Seidl; D J Pritchard
Journal:  Clin Orthop Relat Res       Date:  1997-10       Impact factor: 4.176

Review 2.  Ewing's sarcoma family of tumors: current management.

Authors:  Mark Bernstein; Heinrich Kovar; Michael Paulussen; R Lor Randall; Andreas Schuck; Lisa A Teot; Herbert Juergens
Journal:  Oncologist       Date:  2006-05

Review 3.  Diagnosis and treatment of Ewing's sarcoma.

Authors:  Yukihide Iwamoto
Journal:  Jpn J Clin Oncol       Date:  2007-02-01       Impact factor: 3.019

4.  Prognostic factors in nonmetastatic Ewing's sarcoma of bone treated with adjuvant chemotherapy: analysis of 359 patients at the Istituto Ortopedico Rizzoli.

Authors:  G Bacci; S Ferrari; F Bertoni; S Rimondini; A Longhi; P Bacchini; C Forni; M Manfrini; D Donati; P Picci
Journal:  J Clin Oncol       Date:  2000-01       Impact factor: 44.544

5.  Initial symptoms and clinical features in osteosarcoma and Ewing sarcoma.

Authors:  B Widhe; T Widhe
Journal:  J Bone Joint Surg Am       Date:  2000-05       Impact factor: 5.284

6.  Prognostic factors in Ewing's sarcoma of the foot.

Authors:  Roberto Casadei; Marina Magnani; Roberto Biagini; Mario Mercuri
Journal:  Clin Orthop Relat Res       Date:  2004-03       Impact factor: 4.176

7.  Multifocal Ewing sarcoma of the foot.

Authors:  Hayan Rammal; Ismat Ghanem; Paul-Henri Torbey; Fernand Dagher; Khalil Kharrat
Journal:  J Pediatr Hematol Oncol       Date:  2008-04       Impact factor: 1.289

8.  Local therapy in localized Ewing tumors: results of 1058 patients treated in the CESS 81, CESS 86, and EICESS 92 trials.

Authors:  Andreas Schuck; Susanne Ahrens; Michael Paulussen; Michaela Kuhlen; Stefan Könemann; Christian Rübe; Winfried Winkelmann; Rainer Kotz; Jürgen Dunst; Normann Willich; Heribert Jürgens
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-01-01       Impact factor: 7.038

9.  Do malignant bone tumors of the foot have a different biological behavior than sarcomas at other skeletal sites?

Authors:  M Brotzmann; F Hefti; D Baumhoer; A H Krieg
Journal:  Sarcoma       Date:  2013-03-20
  9 in total
  2 in total

1.  Right third toe swelling.

Authors:  Ramanan Rajakulasingam; Daniel Lindsay; Lee Bayliss; Asif Saifuddin
Journal:  Skeletal Radiol       Date:  2021-01       Impact factor: 2.199

Review 2.  [Foot and ankle tumours : Part II: Malignant bone tumours and soft tissue tumours of the foot with differential diagnostic hints].

Authors:  T Grieser
Journal:  Radiologe       Date:  2018-05       Impact factor: 0.635

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.